Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMNP $3.28 0.3300 +11.19%
RNN $0.74 0.0300 +4.23%
IDRA $2.45 0.0700 +2.94%
BCRX $11.70 0.3300 +2.90%
MYGN $37.60 0.9200 +2.51%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ONTY $1.77 -0.1300 -6.84%
GALT $4.76 -0.3300 -6.48%
DNDN $1.03 -0.0700 -6.36%
NWBO $4.78 -0.3100 -6.09%
Kite $33.69 -2.0600 -5.76%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the Seamless Phase 3 Trial of Sapacitabine in AML

(CNN Money) Oct 9, 2014 - Cyclacel Pharmaceuticals, Inc. today announced that the independent Data and Safety Monitoring Board (DSMB) for the Company's Phase 3 SEAMLESS study in acute myeloid leukemia (AML) has completed its fourth planned safety review and recommended that the study should continue as planned without any modifications.
read article 



Finding Clues in Genes of ‘Exceptional Responders’

(New York Times) Oct 8, 2014 - Grace Silva has a horrible form of thyroid cancer that is considered untreatable — usually, patients are sent to a hospice and die within months of learning they have the disease.
read article 



FDA Delays Decision on Panobinostat New Drug Application

(The Myeloma Beacon) Oct 8, 2014 - The U.S. Food and Drug Administration (FDA) is giving itself an extra two to three months to decide whether to approve panobinostat as a new treatment for mul­ti­ple myeloma.
read article 



Ebola Patient in Dallas Hospital Dies

(USA Today) Oct 8, 2014 - Thomas Duncan, the Liberian national who was the first patient diagnosed with Ebola in the United States, died Wednesday at a Dallas hospital, Texas Health Presbyterian Hospital said.
read article 



Amgen's Humira Copy Succeeds in Skin Disease Trial

(Reuters) Oct 8, 2014 - Amgen Inc said its copycat version of AbbVie Inc's blockbuster biotech drug Humira showed comparable safety and ability to generate immune response in patients with a type of skin disease.
read article 



Free Apps Help Manage Cancer Symptoms and Coordinate Care

(Yahoo! Finance) Oct 7, 2014 - Two new free mobile apps help people facing cancer to better manage the disease by learning how to deal with certain symptoms, and coordinate their care after cancer treatment has ended.
read article 



Pfizer and Breast Cancer Leaders Join Together to Increase Understanding and Dispel Myths about Metastatic Breast Cancer

(Yahoo! Finance) Oct 7, 2014 - This October, Pfizer Inc. is uniting with leaders in the breast cancer community in a public call-to-action to expand the breast cancer dialogue to include metastatic breast cancer.
read article 



IOM Report on End-of-Life Care: A Closer Look

(ASCO in Action) Oct 7, 2014 - ASCO commends the Institute of Medicine (IOM) for its recent report, “Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life.”
read article 



CMS Reopens Hardship Exception Deadline for EHRs

(ACCC) Oct 8, 2014 - The Centers for Medicare & Medicaid Services (CMS) announced on Oct. 7, the agency has reopened the submission period for hardship exception applications for eligible professionals (EPs) and eligible hospitals to avoid the 2015 Medicare payment adjustments for not demonstrating meaningful use (MU) of Certified Electronic Health Record Technology (CEHRT).
read article 



The Sun is Shining. . . .Now What?

(ACCCBuzz) Oct 6, 2014 - On Sept. 30, the Centers for Medicare & Medicaid Services (CMS) released the first round of Open Payments data to the public.
read article 



FDA Finalizes Guidance Aimed at Accelerating Approval for Some Breast Cancer Treatments

(RAPS/Regulatory Focus) Oct 7, 2014 - A new final guidance document issued by the US Food and Drug Administration (FDA) outlines the processes by which the regulator will accept surrogate endpoints to support the accelerated approval of treatments intended for high-risk early-stage breast cancer.
read article 



Blaze Bioscience Announces NCI SBIR Phase II Funding for Clinical Trial of Tumor Paint™ BLZ-100 in Sarcoma

(DigitalJournal.com) Oct 8, 2014 - Blaze Bioscience, Inc. announced today that the company has been awarded a $1.5 million Small Business Innovation Research (SBIR) Phase II contract from the National Cancer Institute (NCI) to study Tumor Paint BLZ-100 in patients with soft tissue sarcoma.
read article 



med fusion and GenomOncology Partner to Match Drug and Clinical Trial Options to Patient Tumors

(GenomOncology) Oct 8, 2014 - med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a partnership to optimize treatment strategies based on the patient’s disease state and tumor profile.
read corporate press release 



Insurance Debate Snares Prostate Study

(Philadelphia Inquirer) Oct 7, 2014 - More than a decade after prostate cancer became the economic driver behind proton beam therapy in the U.S., it still isn't clear that men treated with the technology do better than those who get less costly radiation treatments.
read article 



OXiGENE Announces First Patient Enrolled in Phase 1b/2 Study of Fosbretabulin Combined With Pazopanib in Patients With Advanced Recurrent Ovarian Cancer

(OXiGENE) Oct 7, 2014 - OXiGENE, Inc. today announced that the first patient has been enrolled in a Phase 1b/2 clinical study that will evaluate fosbretabulin in combination with Votrient(TM) (pazopanib) in patients with recurrent ovarian cancer.
read corporate press release 



New 'Lab-on-a-chip' Could Revolutionize Early Diagnosis of Cancer

(University of Kansas) Oct 7, 2014 - Scientists have been laboring to detect cancer and a host of other diseases in people using promising new biomarkers called “exosomes.”
read press release 



Access to Minimally Invasive Colon Cancer Surgery Varies by Location, U-M Study Finds

(U-M CCC) Oct 6, 2014 - Where patients live in the country may determine whether they receive minimally invasive colon cancer surgery, a new study from U-M Comprehensive Cancer Center researchers finds.
read press release 



New At-Risk Group Identified for Gastrointestinal Stromal Tumors

(UC San Diego) Oct 7, 2014 - Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach and small intestine.
read article 



Tampon Test for Ovarian Cancer Shows Promise

(Fox News/LiveScience.com) Oct 8, 2014 - Tampons could one day help doctors spot early-stage ovarian cancer in women at high risk for this deadly disease, a small new study suggests.
read article 



OncoBriefs: Less Chemo for NSCLC, Gleason 7 Gene

(MedPage Today) Oct 7, 2014 - Three or four courses of platinum-based chemotherapy versus six led to similar overall survival in patients with non-small cell lung cancer (NSCLC), authors of a meta-analysis concluded.
read article (free registration required) 



Smokers at Higher Risk for Oral HPV: Study

(Reuters Health) Oct 7, 2014 - Tobacco users are more likely than others to test positive for oral human papillomavirus type 16 (HPV-16), according to a report online Tuesday in JAMA.
read article 



Americans Living Longer as Fewer Die from Heart Disease, Cancer

(Bloomberg) Oct 8, 2014 - A baby born in 2012 will live to a record 78.8 years old on average, as U.S. life expectancy grew and fewer Americans are dying from heart disease, cancer and other chronic illnesses.
read article 



Chimerix Drug Used for Ebola Shows Promise in Respiratory Cases

(Reuters) Oct 8, 2014 - Chimerix Inc said its experimental oral antiviral, which was used earlier this week to treat the first Ebola patient diagnosed in the United States, improved the survival rate of patients with a certain type of respiratory infection.
read article 



Robotic Surgery Brings Higher Costs, More Complications, Study Shows

(Wall Street Journal) Oct 7, 2014 - In the latest study to question the value of robotic surgery, researchers from Columbia University found that the technology costs significantly more and has a higher rate of complications than regular minimally invasive surgery for removing ovaries and ovarian cysts.
read article (paid subscription required) 



Officials Question the Rising Costs of Generic Drugs

(New York Times) Oct 7, 2014 - The prices of some generic drugs have soared more than 1,000 percent in the last year, and federal officials are demanding that generic drug makers explain the reasons for the increases or potentially face new regulation.
read article